Viewing Study NCT04074967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-05 @ 5:46 PM
Study NCT ID: NCT04074967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-06
First Post: 2019-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
Sponsor: Dan Zandberg
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Melanoma View
None Solid Tumor View
None Non-small Cell Lung Cancer View
None Head and Neck Squamous Cell Carcinoma View
Keywords: